HC Wainwright Issues Pessimistic Forecast for Plus Therapeutics (NASDAQ:PSTV) Stock Price
Plus Therapeutics (NASDAQ:PSTV – Get Free Report) had its price target cut by analysts at HC Wainwright from $8.00 to $5.50 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 374.14% from the […]
Plus Therapeutics (NASDAQ:PSTV – Get Free Report) had its price target cut by analysts at HC Wainwright from $8.00 to $5.50 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 374.14% from the […]
